Zinc Supplementation for Dizziness and Chronic Fatigue Syndrome
Zinc supplementation shows potential benefit specifically for chronic fatigue syndrome (CFS/ME/CFS) but has no established role in treating dizziness unless zinc deficiency is documented.
For Chronic Fatigue Syndrome
Zinc combined with melatonin (10 mg zinc + 1 mg melatonin daily for 16 weeks) significantly reduces physical fatigue and improves quality of life in ME/CFS patients 1. This 2021 randomized controlled trial demonstrated meaningful reductions in fatigue perception with good safety profile.
Evidence Supporting Zinc in CFS:
- Lower zinc levels are documented in CFS patients and correlate with symptom severity, immune dysfunction markers (elevated alpha2 proteins, reduced CD69+ T cell activation), and increased oxidative stress 2
- A 2021 trial in elderly patients showed 30 mg daily zinc for 70 days significantly reduced fatigue scores (mean difference: -10.41 vs control, p<0.001) 3
- Multiple systematic reviews identify zinc as one of the few supplements with potential benefit, though evidence quality remains limited 4, 5, 6
Practical Dosing for CFS:
- Start with 10 mg elemental zinc daily combined with 1 mg melatonin for synergistic effect 1
- Alternative: 30 mg elemental zinc daily as monotherapy 3
- Duration: minimum 8-16 weeks to assess response
- Use organic forms (zinc gluconate, zinc histidinate, zinc orotate) over inorganic salts for better tolerability 7
Important Caveats:
Monitor copper levels - zinc supplementation without copper can induce copper deficiency 8. Consider periodic serum copper and zinc measurements during prolonged supplementation 8.
The evidence base has significant limitations: small sample sizes, heterogeneous study designs, and high risk of bias across trials 4, 6. However, given the safety profile at recommended doses and lack of effective standard treatments for CFS, a trial of zinc supplementation is reasonable.
For Dizziness
Zinc has no established therapeutic role for dizziness unless you document zinc deficiency. The FDA-approved indications for zinc are limited to:
- Prevention/treatment of zinc deficiency states in parenteral nutrition 8
- Conditions with documented zinc losses (burns >20% BSA, GI fistulas, chronic diarrhea, stomas) 7, 8
When to Consider Zinc for Dizziness:
Only measure and supplement zinc if the patient has:
- Prolonged parenteral nutrition without adequate zinc supplementation 7
- Major GI losses (ileostomy, enterocutaneous fistula, chronic diarrhea) 7
- Severe malnutrition or hypercatabolic states 7
- Clinical signs of zinc deficiency: parakeratosis, hypogeusia (taste loss), dysosmia (smell disturbance), dermatitis, alopecia 8
Measure plasma zinc with simultaneous CRP and albumin for proper interpretation, as zinc is an acute phase reactant 7.
Safety Considerations
- Doses of 10-30 mg daily are generally safe for oral supplementation
- Acute toxicity occurs at single doses >1-2 mg/kg body weight 8
- Symptoms of excess: nausea, vomiting, profuse sweating, tachycardia, hypothermia 8
- Hyperamylasemia may signal impending zinc overdose 8
- Maximum tolerable intake: avoid exceeding 1-2 grams total zinc 8
Bottom line: For CFS, try zinc 10-30 mg daily for 16 weeks, monitoring copper levels. For dizziness, zinc is not indicated unless deficiency is documented through appropriate testing in at-risk patients.